Scilex Holding Company (NASDAQ:SCLX) does about 2.00M shares in volume on a normal day but saw 4765195 shares change hands in the recent trading day. The company now has a market cap of 110.22M USD. Its current market price is $0.57, marking a decrease of -16.36% compared to the previous close of $0.69. The 52 week high reached by this stock is $2.63 whilst the lowest price level in 52 weeks is $0.46.
Scilex Holding Company (SCLX) has a 20-day trading average at $0.6323 and the current price is -78.15% off the 52-week high compared with 26.06% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.7998 and its 200-day simple moving average is $1.1926. If we look at the stock’s price movements over the week, volatility stands at 12.04%, which increases to 14.74% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 38.39 to suggest the stock is neutral.
The consensus objective for the share price is $11.33, suggesting that the stock has a potential upside of 94.97% over the period.
FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 2 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on October 16, 2024 when Alliance Global Partners initiated the stock to “Buy” and issued a price target of $14. B. Riley Securities initiated its price target at $4.
The current price level is -9.11%, -28.14%, and -51.81% away from its SMA20, SMA50, and SMA200 respectively, with the SCLX price moving above the 50-day SMA on current market day. Scilex Holding Company (SCLX) stock is down -7.41% over the week and -34.72% over the past month. Its price is -71.83% year-to-date and -47.75% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.1 and -0.5 for whole year. Expected sales for next quarter are $19.14M, which analysts say will come at $60.84M for the current fiscal year and next year at $89.81M. In addition, estimates put the company’s current quarterly revenue at an average of $15.64M.
To reach the target analysts have set, the stock logically needs to grow 94.97 percent from here.
Outstanding shares total 191.79M with insiders holding 32.79% of the shares and institutional holders owning 18.16% of the company’s common stock. The beta has a value of 0.96. Price to sales ratio is 2.17.
